Literature DB >> 17363216

Balancing autoaggressive and protective T cell responses.

Abul K Abbas1, Jens Lohr, Birgit Knoechel.   

Abstract

A finely orchestrated balance between activating and inhibitory signals is fundamental for the ability of the immune system to effectively attack and eliminate pathogenic microbes but to not react against self-antigens. Derangements of this balance underlie the pathogenesis of autoimmune diseases. Conversely, elucidating the mechanisms of this balance may provide rational strategies for manipulating it in order to enhance the efficacy of vaccines and tumor immunotherapy. One of the clearest illustrations of precise regulation is in the generation of effector and regulatory T cells. In order to analyze the mechanisms of this regulation, we have developed a transgenic mouse model in which a single population of T cells reacts against its known cognate antigen in vivo. Here we summarize our studies with this experimental model, illustrating the sequence of T cell responses that develop and attempting to dissect the stimuli that control these responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363216      PMCID: PMC2700848          DOI: 10.1016/j.jaut.2007.02.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  12 in total

1.  Role of B7 in T cell tolerance.

Authors:  Jens Lohr; Birgit Knoechel; Estelle C Kahn; Abul K Abbas
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

2.  The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance.

Authors:  Birgit Knoechel; Jens Lohr; Estelle Kahn; Abul K Abbas
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

3.  Functional and molecular comparison of anergic and regulatory T lymphocytes.

Authors:  Birgit Knoechel; Jens Lohr; Shirley Zhu; Lisa Wong; Donglei Hu; Lara Ausubel; Abul K Abbas
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

4.  IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients.

Authors:  Mojgan Ahmadzadeh; Steven A Rosenberg
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

5.  Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

Authors:  V L Perez; L Van Parijs; A Biuckians; X X Zheng; T B Strom; A K Abbas
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

6.  Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

Authors:  E R Kearney; K A Pape; D Y Loh; M K Jenkins
Journal:  Immunity       Date:  1994-07       Impact factor: 31.745

7.  Immune deficiency and autoimmunity.

Authors:  Amos Etzioni
Journal:  Autoimmun Rev       Date:  2003-10       Impact factor: 9.754

Review 8.  Tolerance, not immunity, crucially depends on IL-2.

Authors:  Thomas R Malek; Allison L Bayer
Journal:  Nat Rev Immunol       Date:  2004-09       Impact factor: 53.106

9.  Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen.

Authors:  Birgit Knoechel; Jens Lohr; Estelle Kahn; Jeffrey A Bluestone; Abul K Abbas
Journal:  J Exp Med       Date:  2005-11-14       Impact factor: 14.307

10.  The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells.

Authors:  Nevil J Singh; Ronald H Schwartz
Journal:  J Exp Med       Date:  2003-10-06       Impact factor: 14.307

View more
  36 in total

Review 1.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

2.  CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease.

Authors:  Rudy J Castellani; Summer L Nugent; Alan L Morrison; Xiongwei Zhu; Hyoung-Gon Lee; Peggy L R Harris; Vladan Bajić; Hari S Sharma; Shu G Chen; Peter Oettgen; George Perry; Mark A Smith
Journal:  J Neural Transm (Vienna)       Date:  2010-10-24       Impact factor: 3.575

3.  Dermal immunopathology: from genetics to effector mechanisms.

Authors:  Akira Takashima; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

Review 4.  Innate and adaptive immune response to apoptotic cells.

Authors:  Yufeng Peng; David A Martin; Justin Kenkel; Kang Zhang; Carol Anne Ogden; Keith B Elkon
Journal:  J Autoimmun       Date:  2007-09-20       Impact factor: 7.094

Review 5.  A review of non-cystic fibrosis pediatric bronchiectasis.

Authors:  Eric J Boren; Suzanne S Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

6.  Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells.

Authors:  S Alice Long; Jane H Buckner
Journal:  J Autoimmun       Date:  2008-03-03       Impact factor: 7.094

7.  Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice.

Authors:  Kyung-Chul Yoon; Cintia S De Paiva; Hong Qi; Zhuo Chen; William J Farley; De-Quan Li; Michael E Stern; Stephen C Pflugfelder
Journal:  J Autoimmun       Date:  2007-11-07       Impact factor: 7.094

Review 8.  Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics.

Authors:  Yaron Tomer
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

9.  Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation.

Authors:  Yasuhiro Katsumata; William M Ridgway; Timothy Oriss; Xinyan Gu; David Chin; Yuehong Wu; Noreen Fertig; Tim Oury; Daniel Vandersteen; Paula Clemens; Carlos J Camacho; Andrew Weinberg; Dana P Ascherman
Journal:  J Autoimmun       Date:  2007 Sep-Nov       Impact factor: 7.094

10.  The cyclin dependent kinase inhibitor (R)-roscovitine prevents alloreactive T cell clonal expansion and protects against acute GvHD.

Authors:  Lequn Li; Hui Wang; Jin sub Kim; German Pihan; Vassiliki Boussiotis
Journal:  Cell Cycle       Date:  2009-06-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.